Status | Study |
Active, not recruiting |
Study Name: Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Condition: AIDS-Related Diffuse Large Cell Lymphoma AIDS-Related Plasmablastic Ly Date: 2010-09-01 Interventions: Drug: Cyclophosphamide Given I |
Active, not recruiting |
Study Name: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Condition: Burkitt Lymphoma Diffuse Large B-cell Lymphoma, c-MYC Positive Date: 2010-03-23 Interventions: Drug: EPOCH-R EPOCH-R every 21 |
Terminated |
Study Name: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma Condition: Adult Non-Hodgkin Lymphoma Adult Grade III Lymphomatoid Granulomatosis Date: 2010-01-08 Interventions: Drug: lenalidomide Given orall |
Terminated |
Study Name: Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-01-07 Interventions: Drug: rituximab Given IV |
Completed |
Study Name: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2009-04-29 Interventions: Drug: R-(-)-gossypol acetic acid |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-03-04 Interventions: Drug: fludarabine phosphate Gi |
Completed |
Study Name: A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2006-06-22 Interventions: Drug: cyclophosphamide Given I |
Completed |
Study Name: A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma Condition: Untreated T-cell Angioimmunoblastic Lymphoma Date: 2005-09-12 Interventions: Drug: Rituximab 375 mg/m2 D1 |
Completed |
Study Name: Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Date: 2005-06-02 Interventions: Drug: fludarabine phosphate Gi |
Active, not recruiting |
Study Name: Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer Condition: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplast Date: 2005-03-03 Interventions: Drug: Fludarabine Phosphate Gi |